Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
5.80
-0.29 (-4.76%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Precision Medicines
53.88M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
53.88M